A gene signature to determine metastatic behavior in thymomas.
<h4>Purpose</h4>Thymoma represents one of the rarest of all malignancies. Stage and completeness of resection have been used to ascertain postoperative therapeutic strategies albeit with limited prognostic accuracy. A molecular classifier would be useful to improve the assessment of meta...
Main Authors: | Yesim Gökmen-Polar, Robert W Cook, Chirayu Pankaj Goswami, Jeff Wilkinson, Derek Maetzold, John F Stone, Kristen M Oelschlager, Ioan Tudor Vladislav, Kristen L Shirar, Kenneth A Kesler, Patrick J Loehrer, Sunil Badve |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23894276/?tool=EBI |
Similar Items
-
Molecular analysis of thymoma.
by: Sunil Badve, et al.
Published: (2012-01-01) -
Thymic Carcinomas and Second Malignancies: A Single-Center Review
by: Sunil S. Badve, et al.
Published: (2021-05-01) -
CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer
by: Kelly E. Craven, et al.
Published: (2021-02-01) -
Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study
by: Kristen Meldi Plasseraud, et al.
Published: (2016-01-01) -
Is conservative management of ductal carcinoma in situ risky?
by: Badve, S.S, et al.
Published: (2022)